Muckle Wells syndrome
🔥 During attacks, levels of C-reactive protein (CRP), serum amyloid A (SAA), and the absolute neutrophil count often rise - reflecting systemic inflammation.
🌍 About
- A rare autoinflammatory disorder belonging to the cryopyrin-associated periodic syndromes (CAPS).
- Part of a spectrum that also includes familial cold autoinflammatory syndrome and chronic infantile neurological cutaneous articular syndrome (CINCA).
- First described in the 1960s by Dr. Thomas J. Muckle and Dr. Michael A. Wells.
🧬 Aetiology & Pathophysiology
- Caused by mutations in the NLRP3 gene on chromosome 1q44.
- This results in uncontrolled activation of the NLRP3 inflammasome → excessive caspase-1 activity → overproduction of interleukin-1β (IL-1β).
- IL-1β drives fever, neutrophilia, and tissue inflammation → leading to systemic and organ-specific manifestations.
🩺 Clinical Features
- 🌡️ Recurrent fever and flu-like malaise.
- 🌿 Urticarial rash (non-pruritic, migratory, unlike typical allergy).
- 👁️ Conjunctivitis and sometimes episcleritis.
- 🦴 Arthralgia and fatigue, often worsening with cold exposure.
- 👂 Progressive sensorineural hearing loss (a hallmark feature).
- ⚠️ AA amyloidosis - due to persistent high SAA, leading to nephrotic syndrome and renal failure.
- Occasional: oral ulcers, folliculitis, erythema nodosum.
🔬 Investigations
- 📈 Raised inflammatory markers (CRP, SAA, ESR) during flares.
- 🧪 Urine protein: screen for amyloidosis-related proteinuria.
- 🧬 Genetic testing: confirmation of NLRP3 mutation.
- 👂 Audiometry: monitor hearing loss progression.
💊 Management
The mainstay of treatment is IL-1 blockade, which transforms prognosis by preventing attacks and protecting against amyloidosis:
- 💉 Anakinra: recombinant IL-1 receptor antagonist (daily subcutaneous injection). Produces rapid relief and normalisation of CRP/SAA.
- 💉 Rilonacept: a fusion protein “IL-1 trap” (weekly injection).
- 💉 Canakinumab: fully human monoclonal antibody targeting IL-1β (monthly injection) - increasingly preferred for long-term disease control.
⚠️ Complications
- 🧏 Irreversible sensorineural hearing loss.
- 💧 Renal amyloidosis → proteinuria, nephrotic syndrome, chronic kidney disease.
- 🧠 CNS involvement (rare): headache, papilloedema, chronic meningitis.
📚 Teaching Pearls
- CAPS are autoinflammatory (innate immune dysregulation) not autoimmune (no autoantibodies) - a key exam distinction.
- UK renal clinics often pick up Muckle–Wells late, when patients present with unexplained proteinuria/amyloidosis.
- Early recognition + IL-1 blockade prevents renal failure and disability.
🔗 References
